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1. Introduction
  Hyperlipidemia contributes significantly in the 
manifestation and development of atherosclerosis and 
coronary heart diseases (CHD). Atherosclerosis is a common 
condition in both developed and developing countries 
and is now recognised to be an inflammatory condition 
leading to the development of ischemic heart diseases, 
cerebrovascular diseases and peripheral vascular diseases. 
Ischemic heart disease is a major risk factor in the 
pathogenesis of preoperative adverse cardiovascular events 
which lead to significant morbidity and mortality within 
the high risk surgical patient population[1]. The risk of CHD 
can be reduced by drugs which can lower the lipids and 
cholesterol levels. Modern interest in natural products has 
inspired the search for new effective cholesterol lowering 
agents from these sources.
  Many medicinal plants like Paeonia lactiflora (P. lactiflora)[2],
Pleurospermum kamtschaticum (P. kamtschaticum)[3], 
Ananas comosus (A. comosus)[4] have been reported to reduce 
the lipids and cholesterol levels in body. Lemongrass oil 
is obtained from the leaves of plant Cymbopogon citratus 
(C. citratus), family Poaceae and has been reported to 
have analgesic[5]  antimutagenic[6], antifungal[7] and 
antimicrobial activity[8]. Lemongrass oil, an essential oil 
rich in geraniol and citral, has also been reported to reduce 
cholesterol modestly in hypercholesterolemic subjects[9]. 
However the literature does not show any other study 
for the antihyperlipidemic activity of lemongrass oil in 
experimental animals.
  Hence the present study was undertaken to investigate 
the steam distilled crude extract of leaves of lemongrass 
(lemongrass oil) for anti-hyperlipidemic activity against 
dexamethasone induced hyperlipidemia in rats[10].
2. Materials and methods
2.1. Drugs
  Lemongrass oil (Himalaya Drug Company, Bangalore), 
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atorvastatin (Biocon, Bangalore), dexamethasone sodium 
phosphate (Strides Arco Labs, Bangalore),  biochemical kits 
(Enzokits, Ranbaxy, India), the solvents and other chemical 
used for the study were of analytical grade and purchased 
from local firms.
2.2. Animals
  The inbred Adult male Wistar albino rats (150-200 g) 
were acclimatized for seven days under standard husbandry 
conditions, i.e.; room temperature of (25 依 1)℃; relative 
humidity 45%-55% and a 12:12 h light/ dark cycle. The 
animals had free access to standard rat pellet (Amrut 
feeds, Bombay), with water supplied ad libitum under strict 
hygienic conditions.
  The experimental protocol was approved by the 
Institutional Animal Ethical Committee (IAEC) of Al-
Ameen College of Pharmacy, Bangalore (Karnataka) prior 
to the experiments and all the experiments were conducted 
in strict compliance according to ethical principles and 
guidelines provided by Committee for the Purpose of Control 
and Supervision of Experiments on Animals (CPCSEA).
2.3. Experimental protocol
  Adult male Wistar albino rats (150-200 g) were divided 
into 5 groups, each group consists of six animals. The first 
group of rats fed with normal laboratory diet alone served as 
normal control. The second group of rats were administered 
with dexamethasone (10 mg/kg, sc.) for 8 consecutive days 
served as pathogenic control. The third, fourth and fifth 
group of rats received dexamethasone (10 mg/kg, sc.) and 
simultaneously treated orally with 10 mg/kg atorvastatin, 
100 mg/kg lemongrass oil and 200 mg/kg lemongrass oil 
respectively for 8 consecutive days; the atorvastatin treated 
group was served as a standard. At the end of experimental 
period, all the animals were fasted overnight, blood samples 
were taken through retro-orbital plexus using heparinised 
capillary tubes under light ether anaesthesia. The blood 
was allowed to clot for 30 min at room temperature and 
centrifuged at 5 000 rpm, the upper layer of serum was 
collected in clean centrifuge tubes, which is taken for the 
biochemical analysis. 
  The serum samples were analyzed for cholesterol, 
triglycerides, HDL-cholesterol using the respective 
biochemical kits, while LDL-cholesterol[11] and Atherogenic 
index[12,13] were calculated using the following formula.
LDL-C= Cholesterol - (Triglyceride/5) - HDL-C
Atherogenic index = (Total cholesterol - HDL-C)/HDL-C
2.4. Statistical analysis
  Values are expressed as mean依SEM from 6 animals. 
Statistical differences in mean were analyzed using one way 
ANOVA (analysis of variance) followed by Dunnett’s test. 
P<0.05 was considered significant.
3. Results
  Dexamethasone administration for 8 consecutive days 
caused acute hyperlipidemia in rats wherein the serum 
levels of cholesterol, triglycerides and atherogenic index was 
increased by 167%, 248% and 210% respectively (Table 1).
However, there was no significant difference in serum 
HDL-Cholesterol and LDL-cholesterol levels. In contrast, 
Atorvastatin (10 mg/kg, po.) treatment showed significant 
protection against dexamethasone induced elevated serum 
cholesterol, triglyceride and atherogenic index in statistically 
significant manner (P < 0.05, P < 0.01, P< 0.05 respectively) 
and these values are comparable to normal control group.
Similarly the group of rats treated with lemongrass oil 100 and 
200 mg/kg also showed significant reversal of cholesterol
(P < 0.001 and P < 0.01), triglycerides (P < 0.01 and P < 0.01) 
levels and atherogenic index (P < 0.01 and P < 0.05).
4. Discussion
  The animal  model  o f  dexamethasone induced 
hyperlipidemia in rats is been successfully used for 
evaluating the lipid lowering activity of natural products and 
chemical entities[10,14,15]. The corticoid treatment is known 
to cause an increase in the secretion of VLDL by liver and 
in addition corticoids may also stimulate VLDL formation by 
the intestine. The low level of liver lipoprotein lipase activity 
could have been responsible for the high VLDL-Triglyceride 
level and this also causes imbalance in lipid metabolism 
Table 1
Protective effect of lemongross oil on dexamethasone induced hyperlipidemia in rats (n = 6).
Treatment Cholesterol(mg/dL) Triglycerides(mg/dL) HDL-cholesterol(mg/dL) LDL-cholesterol(mg/dL) Atherogenic index
Normal control 56.37 依 3.11 106.70 依 10.36 21.82 依 1.27 13.21 依 3.50   1.620 依 0.180
Pathogenic control   94.36 依 8.78**   264.80 依 35.15** 22.48 依 3.10 18.92 依 8.11   3.404 依 0.447**
Atorvastatin 10 mg/kg  62.02 依 6.19†   149.30 依 27.43†† 22.61 依 2.54   9.55 依 6.90   1.818 依 0.248†
Lemongrass oil 100 mg/kg     44.06 依 3.94†††   145.50 依 21.79†† 19.06 依 3.16    4.10 依 0.60†   1.541 依 0.364††
Lemongrass oil 200 mg/kg   57.19 依 7.06††   113.50 依 10.45†† 22.13 依 2.42 12.37 依 8.09   1.713 依 0.439†
The values are Mean 依 SEM, (n = 6).  *P<0.05, **P<0.01, ***P<0.001 Pathogenic control vs normal control. †P<0.05, ††P<0.01, †††P<0.001 
Treatments vs pathogenic control.
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leading to hyperlipidemia[14]. In present study, treatment 
with lemongrass oil (100 and 200 mg/kg) has significantly 
reduced  the serum cholesterol, triglycerides levels and 
atherogenic index when compared to dexamethasone per 
se treated animals, indicating the ability of lemongrass oil 
to reverse the hyperlipidemia caused by dexamethasone 
administration.
  Furthermore, the dexamethasone treatment is been 
reported to show an increase in free cholesterol along with 
the decrease in Lecithin cholesterol acetyl transferase 
(LCAT) activity in experimental animals, co-treatment 
with lemongrass oil may be able to reverse the plasma 
free cholesterol levels and LCAT activity near to normal, 
as in case of Garcinia cambogia treated rats[10]. The low 
lipoprotein lipase activity in the liver may be responsible for 
low degradation of lipoprotein, triglycerides and cholesterol. 
Hence the hyperlipidemic effect of dexamethasone was 
found to be reversed by co-treatment with lemongrass oil 
and further this was also found to be comparable with that of 
atorvastatin.
  In the present study, co-administration of lemongrass 
oil (100 & 200 mg/kg, po.) has significantly normalized the 
dexamethasone induced increased in serum cholesterol, 
triglycerides levels and also decreased the atherogenic 
index. These findings would support the therapeutic 
property of lemongrass oil against dexamethasone induced 
hyperlipidemia and hypercholesterolemia in rats.
-
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